Back to today’s briefing

Story perspectives

GLP-1 Medications Surge: Grocery Sales Face $10.8B Loss

7/17/2025

39 4

Summary

Story summary

GLP-1 medications like Ozempic and Mounjaro are transforming the weight loss landscape and boosting testosterone levels for men battling obesity and type 2 diabetes. Yet, this surge in popularity is hitting grocery sales hard, with losses already at $6.5 billion and projected to reach $10.8 billion as more Americans turn to these treatments.

1 of 1

Story summary

GLP-1 medications like Ozempic and Mounjaro are transforming the weight loss landscape and boosting testosterone levels for men battling obesity and type 2 diabetes. Yet, this surge in popularity is hitting grocery sales hard, with losses already at $6.5 billion and projected to reach $10.8 billion as more Americans turn to these treatments.